New research shows that for those afflicted with type 2 diabetes, losing even 15 or 20 pounds can send the disease into remission. Some 400 million people worldwide have type 2 diabetes, a condition…
Immunomedics shares dropped sharply on Monday after the firm presented interim data from its midstage bladder cancer study at the European Society for Medical Oncology (ESMO) Annual Congress in Barcelona, Spain.
ImmunoGen shares dropped on Monday after the firm released data from its late-stage ovarian cancer study at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain.
Dova Pharmaceuticals shares jumped on Monday after the firm announced that it would be acquired by Swedish Orphan Biovitrum, or Sobi. But are Dova investors getting enough out of this acquisition?
These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter ideas.
Pfizer has announced positive top-line results from a second Phase 3 pivotal study evaluating abrocitinib, in patients aged 12 and older with moderate to severe atopic dermatitis.
Between 2009 and 2017, the percentage of American children and teens aged 3 to 17 who were diagnosed with developmental disabilities rose almost 2 percentage points, to almost 18% from just over 16%, with…
Enanta Pharma shares dropped on Thursday after the company announced topline results from its Argon-1 Phase 2a study of EDP-305 for the treatment of non-alcoholic steatohepatitis (NASH).
Amazon has launched a telemedicine smartphone app for some Seattle-based employees. The news dented Teladoc's share price, but not as badly as it might have.
Green tea has long been hailed for a variety of health benefits. Among other things, it is said to improve brain function and physical performance and possibly lower the risk of contracting Alzheimer’s disease,…
Achillion Pharma shares jumped on Wednesday after the firm announced that the FDA has granted Breakthrough Therapy designation for danicopan (ACH-4471).
PhaseBio Pharma shares jumped on Wednesday after the firm announced results from its midstage trial focused on novel therapies for cardiopulmonary orphan diseases.
The September 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
One analyst sees FDA approval of its noninvasive colorectal cancer screening test tacking on another 30% to Exact Sciences stock.
